tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Instil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
PremiumRatingsInstil Bio’s Promising Outlook: Buy Rating Supported by Successful Trials and Market Potential
3M ago
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
Premium
Ratings
Instil Bio Receives Buy Rating Amid Promising Trial Data and Strong Financial Outlook
3M ago
Instil Bio Reports Promising Phase 2 Study Results
Premium
Company Announcements
Instil Bio Reports Promising Phase 2 Study Results
4M ago
Instil Bio Partners with ImmuneOnco for Cancer Therapy
PremiumCompany AnnouncementsInstil Bio Partners with ImmuneOnco for Cancer Therapy
6M ago
Instil Bio price target lowered to $105 from $110 at H.C. Wainwright
Premium
The Fly
Instil Bio price target lowered to $105 from $110 at H.C. Wainwright
6M ago
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
Premium
The Fly
Instil Bio’s Phase 2 trial of asset AXN-2510 to complete enrollment in China
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100